Q32 Bio Inc. (QTTB) Revenue (2018 - 2023)

Q32 Bio has reported Revenue for 6 years, with the latest figure at -$1.4 million in Q4 2023.

• On a quarterly basis, Revenue fell 269.58% year-over-year to -$1.4 million in Q4 2023; TTM through Sep 2024 was -$1.4 million, a 115.43% decrease from a year earlier, with the FY2025 full-year figure at $53.7 million, changed N/A from the prior year.
• Revenue was -$1.4 million for Q4 2023 at Q32 Bio, down from $1.9 million in the prior quarter.
• The five-year high for Revenue was $29.3 million in Q1 2021, with the low at -$1.4 million in Q4 2023.
• Average Revenue over 5 years is $2.4 million, with a median of $802000.0 recorded in 2021.
• The sharpest annual moves came in 2021 and 2023: Revenue surged 4883.84% in 2021, then sank 269.58% in 2023.
• Over 5 years, Revenue stood at $563000.0 in 2019, then jumped by 74.07% to $980000.0 in 2020, then declined by 18.16% to $802000.0 in 2021, then changed by 0.0% to $802000.0 in 2022, then tumbled by 269.58% to -$1.4 million in 2023.
• The last three Revenue figures came in at -$1.4 million (Q4 2023), $1.9 million (Q3 2023), and $3.2 million (Q2 2023), per Business Quant data.